Effects of compounds which inhibit antigenic release of histamine and phagocytic release of lysosomal enzyme on glucose utilization by leukocytes in humans.
D000227:Adenine Nucleotides / Q000494:pharmacology*; D000941:Antigens; D002245:Carbon Dioxide / Q000378:metabolism; D002247:Carbon Isotopes; D002364:Caseins; D000242:Cyclic AMP / Q000494:pharmacology; D003864:Depression, Chemical; D000431:Ethanol / Q000494:pharmacology*; D005947:Glucose / Q000378:metabolism*; D005966:Glucuronidase / Q000378:metabolism; D006636:Histamine Release; D006801:Humans; D066298:In Vitro Techniques; D007782:Lactoglobulins; D007962:Leukocytes / Q000187:drug effects / Q000378:metabolism*; D008247:Lysosomes / Q000201:enzymology; D009536:Niacinamide / Q000494:pharmacology*; D010587:Phagocytosis; D011058:Pollen; D013806:Theophylline / Q000494:pharmacology*; D015054:Zymosan
D000227:Adenine Nucleotides; D000941:Antigens; D002247:Carbon Isotopes; D002364:Caseins; D007782:Lactoglobulins; D002245:Carbon Dioxide; D009536:Niacinamide; D000431:Ethanol; D015054:Zymosan; D013806:Theophylline; D000242:Cyclic AMP; D005966:Glucuronidase; D005947:Glucose